Envista Holdings Corporation (NVST)
- Previous Close
20.02 - Open
19.48 - Bid 20.50 x 1100
- Ask 20.50 x 800
- Day's Range
19.42 - 20.60 - 52 Week Range
18.95 - 38.63 - Volume
1,816,941 - Avg. Volume
2,400,171 - Market Cap (intraday)
3.504B - Beta (5Y Monthly) 1.35
- PE Ratio (TTM)
-- - EPS (TTM)
-0.60 - Earnings Date May 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
23.80
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
envistaco.com12,800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: NVST
Performance Overview: NVST
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NVST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NVST
Valuation Measures
Market Cap
3.50B
Enterprise Value
4.22B
Trailing P/E
--
Forward P/E
13.81
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.33
Price/Book (mrq)
0.84
Enterprise Value/Revenue
1.64
Enterprise Value/EBITDA
24.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.90%
Return on Assets (ttm)
3.10%
Return on Equity (ttm)
-2.39%
Revenue (ttm)
2.57B
Net Income Avi to Common (ttm)
-100.2M
Diluted EPS (ttm)
-0.60
Balance Sheet and Cash Flow
Total Cash (mrq)
940M
Total Debt/Equity (mrq)
39.62%
Levered Free Cash Flow (ttm)
254.2M
Research Analysis: NVST
Company Insights: NVST
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: NVST
NVST: What does Argus have to say about NVST?
ENVISTA HOLDINGS CORP has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetNVST: Lowering target price to $21.00
ENVISTA HOLDINGS CORP has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetNVST: Raising target price to $22.00
ENVISTA HOLDINGS CORP has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetNVST: Rating increased to a HOLD
ENVISTA HOLDINGS CORP has an Investment Rating of HOLD; a target price of $16.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target